Reference : Angioplastie percutanee coronaire chez le patient diabetique. Partie 2: Espoirs appor...
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
Human health sciences : Cardiovascular & respiratory systems
Human health sciences : Surgery
http://hdl.handle.net/2268/10581
Angioplastie percutanee coronaire chez le patient diabetique. Partie 2: Espoirs apportes par les protheses endovasculaires.
French
[en] Percutaneous coronary angioplasty in diabetic patients. Part II: hopes based on endovascular prosthesis
Warzee, Fabian [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation >]
Legrand, Victor mailto [Centre Hospitalier Universitaire de Liège - CHU > > Cardiologie >]
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
2004
Revue Médicale de Liège
59
11
653-8
Yes (verified by ORBi)
National
0370-629X
Belgium
[en] Angioplasty, Transluminal, Percutaneous Coronary ; Coronary Disease/surgery ; Diabetic Angiopathies/surgery ; Humans ; Stents
[en] Coronary artery revascularization procedures provide less favourable results in diabetic patients than in non-diabetic individuals. Especially, percutaneous coronary angioplasty (PTCA) is associated with a higher rate of restenosis and recurrence of cardiac morbidity and death. In diabetic patients, PTCA should, if possible, be combined with a stent. Bare-stents allow to reduce approximately by half the risk of restenosis, but unfortunately their efficacy decreases as the vessel diameter decreases, a common finding among diabetic patients with angiopathy. ARTS ("Arterial Revascularization Therapy Study") recently showed that diabetic patients have a worse prognosis even when bare-stents are combined with PTCA as compared to non-diabetic subjects and as compared to diabetic patients treated with coronary artery bypass graft. These results open new perspectives in favour of the use of drug-eluting stents containing pharmacological agents capable of preventing restenosis. Such new stents might improve the management of diabetic patients with coronary heart disease.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/10581
http://www.rmlg.ulg.ac.be

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
200411_08.pdfNo commentaryPublisher postprint450.29 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.